Loss of Heparin-Releasable Tissue Factor Pathway Inhibitor in Patients Undergoing PTCA

Thromb Haemost 1995; 73(02): 328-329
DOI: 10.1055/s-0038-1653776

Letter to the Editor

Schattauer GmbH Stuttgart

S Anderson

Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK

,

A T Cohen

Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK

,

E Melissari

Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK

,

M S Scully

Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK

,

V V Kakkar

Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK

References
1 Rapaport S. The extrinsic pathway inhibitor: A regulator of tissue-factor dependent blood coagulation. Thromb Haemost 1991; 66: 6-15
2 Broze Jr GJ, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990; 29: 7539-7546
3 Lindahl AK, Sandset PM, Abildgaard U. The present status of tissue factor pathway inhibitor. Blood Coag Fibrinoly 1992; 3: 439-449
4 Ariens RA S, Faioni EM, Mannucci PM. Repeated release of the tissue factor pathway inhibitor. Thromb Haemost 1994; 72: 327-328
5 Sandset PM, Abildgaard U, Pettersen M. A sensitive assay of extrinsic pathway inhibitor (EPI) in plasma and plasma fractions. Thromb Res 1982; 47: 627-636
6 Wilcox JN, Smith KM, Schwartz SM, Gordon D. Selective expression of tissue factor in the normal vessel wall in the atherosclerotic plaque. Proc Natl AcadSci USA 1989; 86: 2829-2834